TRCNF (Transnational Cannabis) Total Stockholders Equity: $34.88 Mil (As of Nov. 2019)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Transnational Cannabis Total Stockholders Equity?

Transnational Cannabis TRCNF -97.50% Total Stockholders Equity is $34.88 Mil as of Nov. 2019.

Transnational Cannabis's Total Stockholders Equity for the quarter that ended in Nov. 2019 was $34.88 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Transnational Cannabis's Book Value per Share for the quarter that ended in Nov. 2019 was $0.05. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Transnational Cannabis's Debt-to-Equity for the quarter that ended in Nov. 2019 was 0.70.


Transnational Cannabis  (OTCPK:TRCNF) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Transnational Cannabis's Book Value per Share for the quarter that ended in Nov. 2019 is

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Transnational Cannabis's Debt-to-Equity for the quarter that ended in Nov. 2019 is

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Transnational Cannabis Total Stockholders Equity Related Terms


Transnational Cannabis Total Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Transnational Cannabis's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Transnational Cannabis Total Stockholders Equity Chart

Transnational Cannabis Annual Data
Trend Feb10 Feb11 Feb12 Feb13 Feb14 Feb15 Feb16 Feb17 Feb18 Feb19
Total Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.15 -0.00 -0.21 -0.08 47.57

Transnational Cannabis Quarterly Data
Feb15 May15 Aug15 Nov15 Feb16 May16 Aug16 Nov16 Feb17 May17 Aug17 Nov17 Feb18 May18 Aug18 Nov18 Feb19 May19 Aug19 Nov19
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 83.78 47.57 108.34 108.08 34.88
What does a Total Stockholders Equity of $34.88 Mil mean?
Transnational Cannabis (TRCNF) has a Total Stockholders Equity of $34.88 Mil as of Nov. 2019. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Transnational Cannabis and its competitors.
Is Transnational Cannabis' Total Stockholders Equity too high?
Transnational Cannabis' current Total Stockholders Equity is $34.88 Mil.
How does Transnational Cannabis' Total Stockholders Equity compare to CLSH and KAYS?
Transnational Cannabis' Total Stockholders Equity of $34.88 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Stockholders Equity for a Drug Manufacturers company?
A good Total Stockholders Equity depends on the Drug Manufacturers industry context. However, Total Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Stockholders Equity mean?
A high Total Stockholders Equity can signal that a stock is expensive relative to its fundamentals. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Transnational Cannabis and its competitors. Transnational Cannabis's current Total Stockholders Equity is $34.88 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Transnational Cannabis stock overvalued right now?
Transnational Cannabis (TRCNF) has a current Total Stockholders Equity of $34.88 Mil. The current Total Stockholders Equity is $34.88 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Stockholders Equity calculated?
Total Stockholders Equity is calculated from a company's financial statements. For Transnational Cannabis (TRCNF), the current Total Stockholders Equity is $34.88 Mil as of Nov. 2019. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Transnational Cannabis Business Description

Address 37 King Street East, Suite 409, Toronto, ON, CAN, M5C 1E9
Transnational Cannabis Ltd, formerly ICC International Cannabis Corp is a Canadian company which is engaged in planning, designing, building and operating cannabis production, processing, and distribution facilities. The company through its holdings is engaged in the pharmaceutical distribution, wholesale importation, research, and development, as well as working interests in industrial hemp licenses in Greece, licenses to cultivate, produce, distribute, store, and export Cannabis and Cannabis derivatives in Colombia, the Kingdom of Lesotho, Africa, and Denmark.